A Study to Evaluate Pneumococcal Polysaccharide Vaccine Effectiveness in Children With Type 1 Diabetes
Last updated on July 2021Recruitment
- Recruitment Status
- Recruiting
- Estimated Enrollment
- Same as current
Summary
- Conditions
- Type 1 Diabetes
- Type
- Interventional
- Phase
- Phase 4
- Design
- Allocation: N/AIntervention Model: Single Group AssignmentIntervention Model Description: Will study immunological response to vaccinationMasking: None (Open Label)Primary Purpose: Prevention
Participation Requirements
- Age
- Between 3 years and 18 years
- Gender
- Both males and females
Description
Not Provided
Not Provided
Tracking Information
- NCT #
- NCT04481243
- Collaborators
- Not Provided
- Investigators
- Principal Investigator: Ana Creo, MD Mayo Clinic
Get Well Soon